Oryzon Receives Approval in Spain to Initiate Phase I for ORY-2001 for Alzheimer’s Disease

by Oryzon Genomics

Epigenetic approaches to modify the progression of various neurodegenerative diseases focus on producing changes in patterns of gene expression in neurons and also in glia cells and are of interest fo...

Read more

Oryzon Genomics Receives 1.3M USD Public Aids to Advance Development of its Epigenetic Inhibitors

by Oryzon Genomics

Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative diseases, announced that the company was granted two unsecured...

Read more

Epigenetics takes the leap from laboratory work benches to the Stock Market

by BioCores

The latest news by Buesa and Maes's company is that they have recently taken a leap onto the Stock Market, after shareholders decided to list on the steady market before spring, as a preliminary step ...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New findings for a better understanding ...

by Universitat de Barcelona

A study published in Pediatric Neurology provides a better understandi...

Photos Stream